Materias dentro de su búsqueda.
Mostrando 701 - 720 Resultados de 58,773 Para Buscar '"Her"', tiempo de consulta: 0.36s Limitar resultados
  1. 701
    por Cumming, E. D.
    Publicado 1889
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Her Heart's Mistake: Chapter XXII.—A Year after
  2. 702
    “…Human epidermal growth factor receptor 2 (HER2 or ErbB2) can be overexpressed, amplified and/or mutated in malignant tumors, and is a candidate for therapeutic targeting. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
  3. 703
    “…This study aimed to investigate the pre-clinical and clinical implication of HER2 as a therapeutic target in BTC. We established two novel HER2-amplified BTC cell lines, SNU-2670 and SNU-2773, from gallbladder cancer patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Therapeutic implication of HER2 in advanced biliary tract cancer
  4. 704
    “…Background: HER2 serves as an important therapeutic target in gastroesophageal cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Gene Signal Distribution and HER2 Amplification in Gastroesophageal Cancer
  5. 705
    “…Trastuzumab-induced cardiotoxicity (TIC) is the primary adverse event that limits the use of trastuzumab in HER2-positive breast cancer patients. However, the incidence and risk factors of TIC in HER2-positive gastric cancer are not known. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
  6. 706
    “…Human epidermal growth factor receptor 3 (HER3) is closely involved in tumor progression and is an important target of therapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prognostic significance of HER3 in patients with malignant solid tumors
  7. 707
    “…Automated assessment of HER-2 expression by ACCEPT on 4084 CTCs of 132 patients showed 8 (6.1%) patients with all CTCs expressing HER-2, 14 (10.6%) patients with no CTC expressing HER-2 and 110 (83.3%) patients with CTCs showing a varying HER-2 expression level. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Quantifying HER-2 expression on circulating tumor cells by ACCEPT
  8. 708
    “…Allelic loss of the autophagy gene, beclin 1/BECN1, increases the risk of patients developing aggressive, including human epidermal growth factor receptor 2 (HER2)-positive, breast cancers; however, it is not known whether autophagy induction may be beneficial in preventing HER2-positive breast tumor growth. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Increased autophagy blocks HER2-mediated breast tumorigenesis
  9. 709
    por Heger, Dörte, Korfhage, Thorben
    Publicado 2018
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Care choices in Europe: To Each According to His or Her Needs?
  10. 710
    “…Multivariate analysis demonstrated that the expression of EGFR, HER-3, HER-4, EGFR/HER-3, EGFR/HER-4 and HER-3/HER-4 was an independent predictor of poor PFS and OS time in osteosarcoma patients with stage I–IIB disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prognostic significance of the expression of HER family members in primary osteosarcoma
  11. 711
    “…AIM: To determine the expression of the HER2 protein in gastric carcinoma and to correlate the expression of a HER2 protein with clinicopathological characteristics of the disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HER2 Positive Gastric Carcinomas and Their Clinico-Pathological Characteristics
  12. 712
    “…Although the prognosis and prediction of therapeutic benefit for breast cancer patients overexpressing the human epidermal growth factor receptor 2 (HER2) have dramatically changed with the administration of anti-HER2-targeted therapies, HER2-positive metastatic breast cancer is still an incurable disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Is there a role for immunotherapy in HER2-positive breast cancer?
  13. 713
    por Flores, Marcella, Johnston, Rowena
    Publicado 2018
    “…Krim was first and foremost a scientist. We highlight her pioneering research in fetal sex determination, as well as her activism during the unfolding AIDS epidemic, which culminated in the cofounding of amfAR, the Foundation for AIDS Research. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Dr. Mathilde Krim: A Scientist and Her Fellowship Legacy
  14. 714
    “…HER2-enriched breast cancer is a complex disease characterized by the overexpression of the ERBB2 amplicon. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Hierarchical Modular Structure of HER2+ Breast Cancer Network
  15. 715
    “…In gastric cancer, HER2 protein overexpression is considered to be conducive to the higher proliferation activity of the tumor cells. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The relationship between HER2 overexpression and angiogenesis in gastric cancer
  16. 716
    “…This case describes the use of novel DNA sequencing technology to provide a targeted treatment option, HER-2 inhibition, in a patient with HER-2 overexpressing ampullary adenocarcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HER-2-Positive Ampullary Adenocarcinoma: A Case Report
  17. 717
    “…OBJECTIVE: To investigate the effect of linc01638 on tumorigenesis in HER2-positive breast cancer. METHODS: We first used qRT-PCR to detect linc01638 expression in HER2-positive breast cancer cells and tissues. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
  18. 718
    “…The copper metallopolymer was found to be highly active for the electrocatalytic hydrogen generation (HER) in an aqueous solution at pH 7.4 and overpotentials at 300 mV vs. reversible hydrogen electrode (RHE). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Copper Metallopolymer Catalyst for the Electrocatalytic Hydrogen Evolution Reaction (HER)
  19. 719
    “…HER3 is the third member of the human epidermal growth factor receptor (HER/EGFR) family, and unlike its other family members, is unique due to its minimal intrinsic kinase activity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
  20. 720
    “…Trastuzumab and pertuzumab are monoclonal antibodies that bind to distinct subdomains of the extracellular domain of human epidermal growth factor receptor 2 (HER2). Adding these monoclonal antibodies to the treatment regimen of HER2-positive breast cancer has changed the paradigm for treatment in that form of cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex
Herramientas de búsqueda: RSS